Manchin Pushback Bad News For Biden But Good News For Biosimilars

Build Back Better Runs Into Roadblock As Democratic Senator Declines Support

 
• By Chloe Kent

Joe Manchin’s refusal to vote in favor of the Biden administration’s Build Back Better legislation could prove to be a boon for the US biosimilars industry, following weeks of condemnation from the Association for Accessible Medicines.

US President Joe Biden hosts West Virginia Senator Joe Manchin in the White House Oval Office to discuss his vote on Biden's Build Back Better Infrastructure initiative
Negotiations between Biden and Manchin have reportedly broken down • Source: Alamy

More from Biosimilars

More from Products